{"id":"W2754791514","doi":"10.1136/annrheumdis-2017-eular.2887","title":"FRI0129 Comparative safety of biologic dmard initiation in ra: a population-based observational study of malignancy risk","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"Janssen Pharmaceuticals; Pfizer Japan; Samsung; Astellas Pharma; Santen; Chugai Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Celltrion; Kissei; Celgene; Biogen; GlaxoSmithKline; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Etanercept; Discontinuation; Internal medicine; Population; Observational study; Golimumab; Abatacept; Oncology; Rheumatoid arthritis; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002438101,0.0006823227,0.001242211,0.0006200534,0.0003603275,0.001300609,0.001117177,0.001406407,0.003301821],"category_scores_gemma":[0.00664072,0.0005266352,0.003547741,0.001093804,0.0004332947,0.0007656139,0.0004795826,0.001534536,0.000525417],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006915547,"about_ca_system_score_gemma":0.0004825819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005157646,"about_ca_topic_score_gemma":0.004118647,"domain_scores_codex":[0.9975987,0.0008683507,0.0003144318,0.0006676333,0.0002741851,0.0002766605],"domain_scores_gemma":[0.9942123,0.001712753,0.002270038,0.001100529,0.0002964941,0.0004078583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.193064,0.001029274,0.7646229,0.0004168272,0.02010003,0.0003707324,0.0001591314,0.0006848063,0.007097627,0.0003045495,0.0008802252,0.01126983],"study_design_scores_gemma":[0.005244419,0.007243655,0.9764658,0.00004168618,0.007638168,0.0005029406,0.0001522225,0.0008043076,0.0007577968,0.0001931889,0.0008982639,0.00005740663],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941465,0.002403798,0.0002262741,0.00007676323,0.00003619425,0.0000163645,0.002452384,0.00001550585,0.000626158],"genre_scores_gemma":[0.9974586,0.0002913349,0.00008900714,0.0000571903,0.00003977253,0.00001251194,0.001774358,0.000005908626,0.000271302],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005157646,"threshold_uncertainty_score":0.01289403,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2734032789014775,"score_gpt":0.4384117512234865,"score_spread":0.1650084723220089,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}